Arizona Bioscience Week Proclamation in the Senate
Wednesday, March 22, 2017, Senator Nancy Barto, Health and Human Services Committee Chair, recognized the work of our researchers, educators, innovators, and healthcare professionals and proclaimed the Week of October 8, 2017 as Arizona Bioscience Week.
On March 22, 2017, Congresswoman Kyrsten Sinema (AZ-09) and Congressman Trey Hollingsworth (IN-09) introduced the Fostering Innovation Act, bipartisan legislation to provide commonsense regulatory relief for companies on the cutting edge of scientific and medical research.
On March 23, 2017, Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or the “Company”) announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of the Controlled Substances Act.
HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has obtained CE marking in the European Union for its HTG EdgeSeq ALKPlus Assay EU.
Critical Path Institute (C-Path) announced the launch of the Type 1 Diabetes (T1D) Consortium. Funded by The Leona M. and Harry B. Helmsley Charitable Trust; Janssen Research & Development, LLC; JDRF International; and Sanofi.
Additional independent studies presented at the 70th Society of Surgical Oncology Annual Cancer Symposium confirm performance and clinical impact of test.
The study was led by Cheryl Nickerson, along with co-authors Jennifer Barrila and Jiseon Yang.
Do YOU have news to share with our community?
Send your news and events to JKW@AZBio.org.